Welcome to the TIGIT Therapies Digital Summit
TIGIT therapies have seen promising clinical validation, spearheading the next wave of Immune Checkpoint Inhibitors. As such there has been an explosion of interest and high-scale investment into this exciting space.
Arriving at a critical point for TIGIT development, the 2nd Annual TIGIT Therapies Summit is the definitive industry-led event focused at propelling this next generation inhibitor to clinical use.
Ensure your TIGIT program reaches full clinical potential through hearing from experts about optimizing the mechanism of action, refining Fc receptor co-engagement, devising effective drug design, rationalizing checkpoint combinations and utilizing biomarkers to harness the therapeutic potential of the TIGIT and DNAM-1/CD226 axes.
Join leaders in TIGIT development from GSK, Gilead Sciences, Arcus, iTeos, Compugen, BeiGene, Seattle Genetics, Mereo BioPharma, Harvard, Stanford and more!
Who attended in 2020?
World-Class Speaker Faculty
